BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 11490019)

  • 1. C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway.
    Soane L; Cho HJ; Niculescu F; Rus H; Shin ML
    J Immunol; 2001 Aug; 167(4):2305-11. PubMed ID: 11490019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublytic C5b-9-stimulated Schwann cell survival through PI 3-kinase-mediated phosphorylation of BAD.
    Hila S; Soane L; Koski CL
    Glia; 2001 Oct; 36(1):58-67. PubMed ID: 11571784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C5b-9 terminal complex protects oligodendrocytes from apoptotic cell death by inhibiting caspase-8 processing and up-regulating FLIP.
    Cudrici C; Niculescu F; Jensen T; Zafranskaia E; Fosbrink M; Rus V; Shin ML; Rus H
    J Immunol; 2006 Mar; 176(5):3173-80. PubMed ID: 16493077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the C5b-9 complement complex in cell cycle and apoptosis.
    Rus HG; Niculescu FI; Shin ML
    Immunol Rev; 2001 Apr; 180():49-55. PubMed ID: 11414362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation.
    Soane L; Rus H; Niculescu F; Shin ML
    J Immunol; 1999 Dec; 163(11):6132-8. PubMed ID: 10570303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cAMP inhibits bile acid-induced apoptosis by blocking caspase activation and cytochrome c release.
    Webster CR; Usechak P; Anwer MS
    Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G727-38. PubMed ID: 12181189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction.
    Negoro S; Oh H; Tone E; Kunisada K; Fujio Y; Walsh K; Kishimoto T; Yamauchi-Takihara K
    Circulation; 2001 Jan; 103(4):555-61. PubMed ID: 11157722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad.
    Shimamura H; Terada Y; Okado T; Tanaka H; Inoshita S; Sasaki S
    J Am Soc Nephrol; 2003 Jun; 14(6):1427-34. PubMed ID: 12761242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells.
    Yang CC; Lin HP; Chen CS; Yang YT; Tseng PH; Rangnekar VM; Chen CS
    J Biol Chem; 2003 Jul; 278(28):25872-8. PubMed ID: 12738789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt-mediated survival of oligodendrocytes induced by neuregulins.
    Flores AI; Mallon BS; Matsui T; Ogawa W; Rosenzweig A; Okamoto T; Macklin WB
    J Neurosci; 2000 Oct; 20(20):7622-30. PubMed ID: 11027222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning.
    Uchiyama T; Engelman RM; Maulik N; Das DK
    Circulation; 2004 Jun; 109(24):3042-9. PubMed ID: 15184284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt.
    del Peso L; González-García M; Page C; Herrera R; Nuñez G
    Science; 1997 Oct; 278(5338):687-9. PubMed ID: 9381178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Bcl-2-associated death protein and counter-response of Akt within cell populations during seizure-induced neuronal death.
    Henshall DC; Araki T; Schindler CK; Lan JQ; Tiekoter KL; Taki W; Simon RP
    J Neurosci; 2002 Oct; 22(19):8458-65. PubMed ID: 12351720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3K inhibition in neonatal rat brain slices during and after hypoxia reduces phospho-Akt and increases cytosolic cytochrome c and apoptosis.
    Hirai K; Hayashi T; Chan PH; Zeng J; Yang GY; Basus VJ; James TL; Litt L
    Brain Res Mol Brain Res; 2004 Apr; 124(1):51-61. PubMed ID: 15093685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation.
    Kang YC; Kim KM; Lee KS; Namkoong S; Lee SJ; Han JA; Jeoung D; Ha KS; Kwon YG; Kim YM
    Cell Death Differ; 2004 Dec; 11(12):1287-98. PubMed ID: 15297884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria.
    Kennedy SG; Kandel ES; Cross TK; Hay N
    Mol Cell Biol; 1999 Aug; 19(8):5800-10. PubMed ID: 10409766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
    Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
    Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation.
    Hatano E; Brenner DA
    Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1357-68. PubMed ID: 11705740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-x(S) induces an NGF-inhibitable cytochrome c release.
    Lindenboim L; Schlipf S; Kaufmann T; Borner C; Stein R
    Exp Cell Res; 2004 Jul; 297(2):392-403. PubMed ID: 15212942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of PI3-kinase/PKB contributes to delay in neutrophil apoptosis after thermal injury.
    Hu Z; Sayeed MM
    Am J Physiol Cell Physiol; 2005 May; 288(5):C1171-8. PubMed ID: 15625305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.